Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Amgen Inc (AMGN)

2014-10-21@16:07:12 ET
Closing Update: Earnings Fuel Rally on Wall Street; Technical Levels Compromised (MID)

2014-10-21@15:41:00 ET
Amgen Statement Regarding Third Point Investment (PRN)

2014-10-21@13:50:52 ET
Amgen (AMGN) Breaks Through Resistance at $139.04 (F79)

2014-10-21@11:05:37 ET
Amgen (AMGN) Showing Bullish Technicals With Resistance At $140.56 (FBM)

2014-10-21@10:03:10 ET
Amgen files patent infringement law suit against Sanofi and Regeneron (DTM)

2014-10-21@09:00:00 ET
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA (PRN)

2014-10-21@04:54:36 ET
Form 3: Initial Filing for Amgen Inc (AMGN) (VKR)

2014-10-21@04:50:52 ET
Monoclonal Antibody Industry 2014-2019 Global and China A New Research Report at ChinaMarketResearchReports.com (PRW)

2014-10-20@14:44:14 ET
Daily Dividend Report: HAL, VFC, ERF, AMGN, NEE, MOS, SJM, SEE (MNV)

2014-10-20@11:05:40 ET
Amgen appoints new director (DTM)

2014-10-20@09:00:00 ET
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma (PRN)

2014-10-20@08:26:28 ET
Amgen (AMGN) Trading Near $144.70 Resistance Level (FBM)

2014-10-20@07:33:23 ET
Amgen to pay dividend to stockholders of record of 13 November 2014 (MTO)

2014-10-18@20:41:54 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-10-17@20:42:24 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-10-17@17:15:14 ET
8-K: AMGEN INC (EDK)

2014-10-17@16:40:22 ET
After Yesterday's Rally of 2.48% Shares Could Potentially Pullback (PSM)

2014-10-17@16:39:51 ET
Amgen Rises 2.48% on Heavy Volume: Watch For Potential Pullback (PSM)

2014-10-17@16:17:00 ET
Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors (PRN)